UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 16, 2009
RXI PHARMACEUTICALS CORPORATION
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
001-33958
|
|
20-8099512 |
|
|
|
|
|
|
(State or other jurisdiction of
of incorporation or organization)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.) |
60 Prescott Street, Worcester, MA 01605
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (508) 767-3861
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
(c) On October 16, 2009, the Board of Directors (the “Board”) of RXi Pharmaceuticals Corporation
(the “Company”) appointed Amy Tata, CPA to the position of Principal Accounting Officer and
Controller of the Company, effective immediately. Ms. Tata, age 36, joined the Company in June
2007 as the Director of Accounting. Over the past two years, she has been responsible for the
administration of the Company’s accounting and SEC reporting as well as Sarbanes-Oxley
implementation and compliance. Prior to joining the Company, Ms. Tata served from January 2006
until May 2007, as the Director of Finance and Business Operations of Girls Incorporated of
Worcester, a national non-profit organization which provides research based educational programs to
girls and young women. From December 1999 until December 2005, she held various positions,
including Audit Manager, at Carlin, Charron and Rosen LLP, a regional certified public accounting
firm which provides assurance, financial and business advisory services to both public and private
companies. Ms. Tata is a Massachusetts licensed CPA and holds a degree in accounting. Ms. Tata
does not have a family relationship with any existing member of the Board or any executive officer
of the Company.
(e) On October 16, 2009, the Board of the Company voted to approve the recommendation of the
Company’s Compensation Committee to increase the annual base salary of Pamela Pacvo, Ph.D., Vice
President of Pharmaceutical Development, from $270,000 to $278,667. Dr. Pavco’s new base salary is effective
retroactively to August 1, 2009.